The enduring success of sildenafil has undeniably shaped the drug landscape. However, investing in companies heavily focused on biosimilars and the declining patent exclusivity surrounding this iconic https://wearethelist.com/story23544463/viagra-and-pharmaceutical-companies-a-risky-opportunity